VVOS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Vivos Therapeutics Inc (VVOS) is not a strong buy at the moment for a beginner, long-term investor. Despite significant revenue growth in the latest quarter, the company remains unprofitable with negative earnings and declining gross margins. The technical indicators suggest a bearish trend, and there are no significant positive catalysts or trading signals to support an immediate purchase.
The stock is in a bearish trend with the MACD histogram below zero and negatively expanding, RSI at 29.509 in the neutral zone, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 1.318, and resistance is at 1.608. The stock is trading below its pivot point of 1.463.
Revenue increased by 75.73% YoY in Q3 2025, and net income improved by 106.42% YoY.
Gross margin dropped by 7.59% YoY, indicating potential cost pressures. No recent news or significant trading trends from hedge funds or insiders.
In Q3 2025, revenue grew significantly by 75.73% YoY to $6.78M, but the company reported a net loss of -$5.4M. EPS improved by 22.50% YoY to -0.49, but gross margin declined to 52.38%, down 7.59% YoY.
No recent analyst ratings or price target changes are available.
